Ignite Creation Date:
2025-12-25 @ 4:48 AM
Ignite Modification Date:
2026-05-25 @ 10:01 AM
Study NCT ID:
NCT00388518
Status:
COMPLETED
Last Update Posted:
2016-11-02
First Post:
2006-10-16
Is NOT Gene Therapy:
True
Has Adverse Events:
False
Brief Title:
A Study of Aleglitazar in Patients With Type 2 Diabetes
Sponsor:
Hoffmann-La Roche
Organization:
Organization Data
Organization:
Class:
INDUSTRY
Study ID:
BM17864
Study Type:
None
Study Domain:
None
Study Link:
None
Lead Sponsor:
Lead Sponsor Class:
INDUSTRY
Responsible Party:
Responsible Party Title:
Responsible Party Type:
SPONSOR
Responsible Party Affiliation:
Old Name:
None
Old Organization:
None